Literature DB >> 7972764

Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging.

T C Ng1, Y G Comair, M Xue, N So, A Majors, H Kolem, H Luders, M Modic.   

Abstract

PURPOSE: To assess two-dimensional phase-encoded proton chemical shift imaging for potential clinical application in presurgical localization of temporal lobe epilepsy (TLE).
MATERIALS AND METHODS: Interictal chemical shift imaging studies were performed in 25 patients (17 unilateral, eight bilateral epileptogenic abnormalities) and 12 healthy volunteers. Results were compared with those of electroencephalography. For each temporal lobe, the volume of interest (VOI) included mesial, lateral, anterior, and posterior areas.
RESULTS: The epileptogenic zone was characterized by an abnormal pattern of decreased signal intensity in the N-acetylaspartate (NAA) peak, either increased or unchanged choline (Cho) level relative to creatine (Cr) signal intensity, and, occasionally, elevated lactate level. NAA/Cho was the most sensitive and reliable quantitative marker for abnormality. The sensitivity and specificity of this technique compared with EEG were 90% and 85%, respectively. The difference in NAA/Cho between epileptogenic and normal temporal lobes was highly significant (P < .001). No statistically significant difference was found between normal temporal lobes and patients' uninvolved temporal lobes.
CONCLUSION: NAA/Cho is an excellent marker for localizing the epileptogenic zone in TLE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972764     DOI: 10.1148/radiology.193.2.7972764

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.

Authors:  Filip Jírů; Monika Dezortová; Martin Burian; Milan Hájek
Journal:  MAGMA       Date:  2003-10-16       Impact factor: 2.310

2.  Extent of preoperative abnormalities and focus lateralization predict postoperative normalization of contralateral 1H-magnetic resonance spectroscopy metabolite levels in patients with temporal lobe epilepsy.

Authors:  G Lantz; M Seeck; F Lazeyras
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Assessment of the preferred scout sagittal orientation for temporal lobe imaging with magnetic resonance.

Authors:  P M Gonçalves Pereira; E Oliveira; M F Secca
Journal:  MAGMA       Date:  2004-12-03       Impact factor: 2.310

4.  Proton MR spectroscopy in patients with acute temporal lobe seizures.

Authors:  M Castillo; J K Smith; L Kwock
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

5.  Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 tesla.

Authors:  Jullie W Pan; Kai-Ming Lo; Hoby P Hetherington
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

6.  Localized proton MR spectroscopy of the allocortex and isocortex in healthy children.

Authors:  C G Choi; T S Ko; H K Lee; J H Lee; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

7.  Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging.

Authors:  G R Ende; K D Laxer; R C Knowlton; G B Matson; N Schuff; G Fein; M W Weiner
Journal:  Radiology       Date:  1997-03       Impact factor: 11.105

Review 8.  [(1)H MR spectroscopy. Methods and applications in diagnosis and assessment of surgical and conservative treatment strategies in epilepsies].

Authors:  T Hammen; H Stefan
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 9.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

10.  Multivoxel proton MR spectroscopy in malformations of cortical development.

Authors:  C C Leite; L T Lucato; J R Sato; K D Valente; M C G Otaduy
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.